LSE company dividends information has been updated. You can find this is in the menu on any Quote page. ADVFN team.


Reneuron Group Plc

1.00 (17.09%)
Share Name Share Symbol Market Type Share ISIN Share Description
Reneuron Group Plc LSE:RENE London Ordinary Share GB00BF5G6K95 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  1.00 17.09% 6.85 1,003,868 15:37:18
Bid Price Offer Price High Price Low Price Open Price
6.70 7.00 6.85 5.85 5.85
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceutical Preparations 0.40 -9.69 -17.00 - 3.92
Last Trade Time Trade Type Trade Size Trade Price Currency
15:49:05 O 10,000 6.725 GBX

Reneuron (RENE) Latest News

Reneuron (RENE) Discussions and Chat

Reneuron (RENE) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type

Reneuron (RENE) Top Chat Posts

Top Posts
Posted at 25/5/2023 13:14 by dickbush
It looks like Obotritia Capital is providing a tap. I just bought some at very close to the bid price. It's marked as a sale.
Posted at 18/5/2023 10:28 by thiopia
Investor presentation

ReNeuron Group plc (AIM: RENE) , a UK-based leader in stem cell derived exosome technologies , will announce its preliminary results for the year ended 31 March 2023 on Thursday 25 May 2023.

Investor Briefing

Management will also be hosting a live online presentation relating to the preliminary results via the Investor Meet Company platform at 9:30am BST on Thursday 25 May 2023. The presentation is open to all existing and potential shareholders.

Investors can sign up to Investor Meet Company for free and register for the presentation here:


Investors who already follow ReNeuron on the Investor Meet Company platform will automatically be invited.

Questions can be submitted pre-event via your IMC dashboard or in real time during the presentation, via the "Ask a Question" function. Whilst the Company may not be in a position to answer every question it receives, it will address the most prominent within the confines of information already disclosed to the market through regulatory notifications. A recording of the presentation, a PDF of the slides used, and responses to the Q&A session will be available on the Investor Meet Company platform afterwards.

Posted at 16/5/2023 19:24 by pdt
This now looks interesting. Market cap of £4m and holds cash of around £6m. Some recent buying by Directors and NED. They have a cash runway into 2024 to be able to commercialise their exosome platform. Share price about 7p and brokers have targets around 70p. Seems high risk / high reward opportunity? I have made a small investment today that I am prepared to lose 100% of it. Be interesting to see what happens over the next 6 to 9 months.
Posted at 27/1/2023 14:22 by the stigologist
12th December 2022 RNS he went below 3%


Posted at 27/1/2023 14:18 by glavey
Richard Griffiths had a significant holding here, I don't see any notification of change.

Posted at 19/1/2023 09:05 by the stigologist
Directors Deals for Reneuron (RENE)

Announced Action Notifier Price Currency Amount

02-Sep-22 Buy Iain G Ross 27.70 GBX 60,000
02-Sep-22 Buy Iain G Ross 26.00 GBX 30,000
02-Sep-22 Buy Iain G Ross 25.85 GBX 10,000
14-Jul-22 Buy Catherine Isted 31.90 GBX 50,000
13-Jul-22 Buy Barbara Staehelin 30.32 GBX 127,000

Expect to see some averaging down given buys within last 6 months in 25-31p range

Posted at 18/12/2022 13:56 by profit7
770% to level with the valuation
#RENE #RENUERON currently 10.5p [...]
We continue to value ReNeuron at £44.2m or 77p per share. [...]

Posted at 18/12/2022 13:50 by profit7



Posted at 18/12/2022 13:44 by profit7
RENE was at 30p,
Seller took this to 10p

Oversold on The charts, looks primed to go on a run.
Santa run coming ON RENE

Posted at 18/12/2022 13:26 by profit7
Way undervalued RENE

Mcap £6M

Cash £10M that c77% discount Share price from cash level.

Reneuron share price data is direct from the London Stock Exchange
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 |

V: D: 20230602 15:04:25